We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

170 hedge funds and large institutions have $818M invested in Natus Medical Inc in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 57 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more call options, than puts

Call options by funds: $1.89M | Put options by funds: $793K

100% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 14

9% more funds holding

Funds holding: 156170 (+14)

4% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 55

0% less capital invested

Capital invested by funds: $819M → $818M (-$539K)

Holders
170
Holders Change
+14
Holders Change %
+8.97%
% of All Funds
2.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
57
Reduced
55
Closed
14
Calls
$1.89M
Puts
$793K
Net Calls
+$1.09M
Net Calls Change
+$2.07M
Name Holding Trade Value Shares
Change
Change in
Stake
Los Angeles Capital Management
176
Los Angeles Capital Management
California
-$453K -17,705 Closed
AIM
177
Aigen Investment Management
New York
-$285K -11,140 Closed
GCP
178
GSA Capital Partners
United Kingdom
-$213K -8,319 Closed
BCM
179
Beddow Capital Management
Wyoming
-$205K -8,000 Closed
SG Americas Securities
180
SG Americas Securities
New York
-$109K -4,242 Closed
Simplex Trading
181
Simplex Trading
Illinois
-$41.1K -1,511 Closed
FMT
182
First Mercantile Trust
Tennessee
-$30K -1,187 Closed
PHK
183
Point72 Hong Kong
Hong Kong
-$3K -123 Closed
LPWM
184
Lake Point Wealth Management
Texas
+$272 +10 New

NTUS Hedge Fund Activity: Q2 2021 in Review

170 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2021, worth a combined $818M — down 0.07% from $819M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new NTUS positions and 14 closed out — a net gain of 14 holders — while 57 added to existing stakes and 55 trimmed.

The largest buyer was Tributary Capital Management, opening a new position worth an estimated $11.1M. The largest seller was Invesco, cutting an estimated $10.7M.

  • 170 institutional investors held Natus Medical Inc (NTUS) as of Q2 2021, up from 156 in Q1 2021.
  • Funds reported $818M of Natus Medical Inc stock for Q2 2021, down 0.07% quarter-over-quarter.
  • 28 funds opened new Natus Medical Inc positions in Q2 2021 and 14 closed out, a net change of +14 holders.
  • The largest Natus Medical Inc buyer in Q2 2021 was Tributary Capital Management, an estimated $11.1M added.
  • The largest Natus Medical Inc seller in Q2 2021 was Invesco, an estimated $10.7M sold.

Based on aggregated 13F filings for Q2 2021.